Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy

Lisette M. Wiltink, Remi A. Nout, Jochem R.N. van der Voort van Zyp, Heleen M. Ceha, Marta Fiocco, Elma Meershoek-Klein Kranenbarg, Andreas W.K.S. Marinelli, Cornelis J.H. van de Velde, Corrie A.M. Marijnen

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

Long-term health-related quality of life is compared between patients with rectal cancer preoperatively treated with long-course chemo radiotherapy (CRT) or with short-course radiotherapy. Apart from less satisfaction with urinary function reported by patients who had CRT, no clinically relevant differences in health-related quality of life and patient-reported symptoms between patients who had CRT and short-course radiotherapy were found at 5 years after rectal cancer treatment. Background Both preoperative short-course radiotherapy (SC-PRT) and preoperative long-course chemo radiotherapy (CRT) have shown to reduce local recurrence rates after total mesorectal excision (TME), but neither resulted in improved survival. This study compared the long-term health-related quality of life (HRQL) and symptoms between CRT and SC-PRT. Methods Patients who were preoperatively treated with a total dose of 50.0 to 50.4 Gy for locally advanced rectal cancers were identified from 2 hospital registries. Starting from 2011, all patients who were disease-free in the study population (n = 105) were sent a HRQL-questionnaire composed of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and questions on bowel and urinary function. Patients who underwent SC-PRT in the TME trial were used as a reference group. Results HRQL results from 85 patients receiving CRT (81.0%), with a median follow-up time of 58 months, were compared with the results of patients who underwent SC-PRT (n = 306). Apart from more nausea and vomiting reported by patients receiving CRT (mean score for CRT 5.9 vs. 1.3 for SC-PRT; P < .01; not clinically relevant) and less satisfaction with urinary function indicated by patients who received CRT (mean score for CRT 71.2 vs. 81.2 for SC-PRT; P < .01), no significant differences were found in HRQL and symptoms between patients who received CRT and SC-PRT. Conclusions This analysis of HRQL in patients who received CRT shows no clinically relevant differences in long-term HRQL and symptoms between patients who received CRT and SC-PRT, apart from less satisfaction with urinary function reported by patients who received CRT. These results indicate that both approaches have a comparable impact on long-term HRQL.

Original languageEnglish
Pages (from-to)e93-e99
JournalClinical Colorectal Cancer
Volume15
Issue number3
DOIs
Publication statusPublished - 1 Sept 2016
Externally publishedYes

Keywords

  • Adverse effects
  • Chemoradiotherapy
  • Health-related quality of life
  • Long-term follow-up
  • Rectal cancer

Fingerprint

Dive into the research topics of 'Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy'. Together they form a unique fingerprint.

Cite this